Aarti Pharmalabs Limited (APL) has announced a strategic joint venture with Ganesh Polychem Limited (GPL), effective from the close of business hours on March 31, 2025. This development follows an Addendum to the Subscription and Shareholders Agreement between APL and Hemant Bandodkar & Family (Bandodkars).
As per the agreement, APL will consolidate its financial statements using the Equity Method from April 1, 2025. The partnership aims to enhance operational efficiencies and expand business synergies. Notably, the agreement does not grant any special rights to either party, ensuring a balanced collaboration.
The Bandodkars are not related to APL’s promoter group, and the transaction does not fall under related party transactions. Additionally, no fresh shares will be issued under this agreement.
This strategic alliance aligns with APL’s growth objectives, strengthening its market position in the pharmaceutical sector. By leveraging combined expertise and resources, APL and GPL are set to drive innovation and business expansion.
